Royal Surrey County Hospital
Guildford, Surrey, GU2 7XX, United Kingdom
NCT Number: NCT03283683
This study evaluates the use of actigraphy-derived measures to improve prognostication in patients with advanced cancer.
Looking for future studies?
Notify MeAn accurate assessment of prognosis (life expectancy) is important for cancer patients, their carers, and their health care professionals. In the case of patients / their carers, it allows them to plan for the future, and to make more informed decisions about further anti-cancer treatments, and about referral to supportive and palliative care services. However, previous research suggests that health care professionals are not particularly good at estimating prognosis, and frequently over-estimate prognosis.
The aim of this project is to assess the usefulness of measuring physical activity, and differences between daytime and nighttime physical activity, in determining prognosis in patients with cancer. Studies suggest that these measures may be useful in determining prognosis in certain groups of patients with cancer (e.g. patients receiving chemotherapy for colon / rectum cancer). However, these studies need to be repeated in patients with different types of cancer, and also patients receiving other types of treatment (including supportive and palliative care). The aim of this small scale ("feasibility") study is to determine whether or not a large scale ("definitive") study can be done.
The feasibility study will include 50 patients with cancer, who will be asked to rate their performance status (physical activity) on a well-used scale, and then to wear a watch-like device for one week that measures physical activity and sleep patterns. The researcher will collect a blood sample: some of which will be used for analysis of parameters, which have previously been identified as prognostic indicators and will collect and store some blood for future transcriptome analysis. Participants will also be asked to complete a sleep diary during the week, and a questionnaire about their symptoms at the beginning and end of the week. The study will last one week in total and is collaboration between the Royal Surrey County Hospital, and the University of Surrey (Surrey Sleep Research Centre).
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 7 days.
Compares the amount of activity of the patient when in bed to when the patient is out of bed. An actigraphy-derived percentage of the activity counts, measured when the patient is in bed, that are inferior to (lower than) the median of the activity counts measured when the patient is out of bed.
Time frame: upto 7 days
An actigraphy-derived 24hr correlation coefficient that reports on how reproducible the patient's activity is every 24 hours.
Time frame: 7 days.
calculated as the average number of wrist movements per minute throughout the recording time
Time frame: 7 days
Parameters during the presumed sleep phase of the circadian cycle; eg: Time in bed, sleep efficiency e.t.c
Time frame: Day 0 actigraphy and Day 8 actigraphy
Physician's assessment of the patient's ECOG-Performance Status. The Eastern Cooperative Oncology Group performance scale (ECOG-PS) is a standardised measure for quantifying the functional status of patients with cancer and includes a numerical / categorical scale
Time frame: Day 0 actigraphy and Day 8 actigraphy
Patient's assessment of their own ECOG-Performance Status
Time frame: Day 0 actigraphy and Day 8 actigraphy
The MSAS-SF is a validated symptom assessment tool that has been used extensively in oncology / palliative care research and includes questions on both physical and psychological symptoms.
Time frame: Day 8 actigraphy
This is a validated, self-rated questionnaire, which measures sleep quality and disturbances over a 1-month time period
Time frame: Day 0 actigraphy
Compare actigraphy-derived circadian / sleep parameters against other validated prognostic indicators
Time frame: Day 0 actigraphy
Compare actigraphy-derived circadian / sleep parameters against other validated prognostic indicators
Royal Surrey County Hospital NHS Foundation Trust
Other
Acronym: AIPACa
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07524179
Cancer, Chronic Disease
Erzurum, Merkez, Turkey (Türkiye)
View Trial DetailsNCT03430141
Cancer, Cardiovascular Diseases
Flagstaff, Arizona, United States
View Trial DetailsNCT00178204
Cancer, Fatigue
Rochester, New York, United States
View Trial DetailsNCT05601206
Behavior, Behavioral Symptoms
Pittsburgh, Pennsylvania, United States
View Trial Details